RECERCAT Home
>
Universitat Internacional de Catalunya
>
Recerca
>
Articles
>
Ciències de la Salut
>
View document
To access the full text documents, please follow this link: http://hdl.handle.net/20.500.12328/2666
| dc.contributor.author | Pujol, Miquel |
|---|---|
| dc.contributor.author | Miró, José-María |
| dc.contributor.author | Shaw, Evelyn |
| dc.contributor.author | Aguado, Jose-María |
| dc.contributor.author | San-Juan, Rafael |
| dc.contributor.author | Puig-Asensio, Mireia |
| dc.contributor.author | Pigrau, Carles |
| dc.contributor.author | Calbo Sebastián, Esther |
| dc.contributor.author | Montejo, Miguel |
| dc.contributor.author | Rodriguez-Álvarez, Regino |
| dc.contributor.author | Garcia-Pais, María-Jose |
| dc.contributor.author | Pintado, Vicente |
| dc.contributor.author | Escudero-Sánchez, Rosa |
| dc.contributor.author | Lopez-Contreras, Joaquín |
| dc.contributor.author | Morata, Laura |
| dc.contributor.author | Montero, Milagros |
| dc.contributor.author | Andrés, Marta |
| dc.contributor.author | Pasquau, Juan |
| dc.contributor.author | Arenas, María-del-Mar |
| dc.contributor.author | Padilla, Belén |
| dc.contributor.author | Murillas, Javier |
| dc.contributor.author | Jover-Sáenz, Alfredo |
| dc.contributor.author | López-Cortes, Luis-Eduardo |
| dc.contributor.author | García-Pardo, Graciano |
| dc.contributor.author | Gasch, Oriol |
| dc.contributor.author | Videla, Sebastian |
| dc.contributor.author | Hereu, Pilar |
| dc.contributor.author | Tebé, Cristian |
| dc.contributor.author | Pallarès, Natalia |
| dc.contributor.author | Sanllorente, Mireia |
| dc.contributor.author | Domínguez, María-Ángeles |
| dc.contributor.author | Càmara, Jordi |
| dc.contributor.author | Ferrer, Anna |
| dc.contributor.author | Padullés, Ariadna |
| dc.contributor.author | Cuervo, Guillermo |
| dc.contributor.author | Carratalà, Jordi |
| dc.contributor.author | MRSA Bacteremia (BACSARM) Trial Investigators |
| dc.date | 2021-07-02T12:31:30Z |
| dc.date | 2021-07-02T12:31:30Z |
| dc.date | 2020 |
| dc.identifier | Pujol, Miquel; Miró, José-María; Shaw, Evelyn [et al.]. Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial. Clinical Infectious Diseases, 2020, 72(9), p. 1517-1525. Disponible en: <https://academic.oup.com/cid/article/72/9/1517/5877897>. Fecha de acceso: 2 jul. 2021. DOI: 10.1093/cid/ciaa1081 |
| dc.identifier | 1058-4838 |
| dc.identifier | http://hdl.handle.net/20.500.12328/2666 |
| dc.identifier | https://dx.doi.org/10.1093/cid/ciaa1081 |
| dc.identifier.uri | http://hdl.handle.net/20.500.12328/2666 |
| dc.description | Background: We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis. Methods: A randomized (1:1) phase 3 superiority, open-label, and parallel group clinical trial of adult inpatients with MRSA bacteremia was conducted at 18 Spanish hospitals. Patients were randomly assigned to receive either 10 mg/kg of daptomycin intravenously daily plus 2 g of fosfomycin intravenously every 6 hours, or 10 mg/kg of daptomycin intravenously daily. Primary endpoint was treatment success 6 weeks after the end of therapy. Results: Of 167 patients randomized, 155 completed the trial and were assessed for the primary endpoint. Treatment success at 6 weeks after the end of therapy was achieved in 40 of 74 patients who received daptomycin plus fosfomycin and in 34 of 81 patients who were given daptomycin alone (54.1% vs 42.0%; relative risk, 1.29 [95% confidence interval, .93–1.8]; P = .135). At 6 weeks, daptomycin plus fosfomycin was associated with lower microbiologic failure (0 vs 9 patients; P = .003) and lower complicated bacteremia (16.2% vs 32.1%; P = .022). Adverse events leading to treatment discontinuation occurred in 13 of 74 patients (17.6%) receiving daptomycin plus fosfomycin, and in 4 of 81 patients (4.9%) receiving daptomycin alone (P = .018). Conclusions: Daptomycin plus fosfomycin provided 12% higher rate of treatment success than daptomycin alone, but this difference did not reach statistical significance. This antibiotic combination prevented microbiological failure and complicated bacteremia, but it was more often associated with adverse events. |
| dc.format | 9 |
| dc.format | application/pdf |
| dc.language | eng |
| dc.publisher | Oxford University Press |
| dc.relation | Clinical Infectious Diseases |
| dc.relation | 72;9 |
| dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights | info:eu-repo/semantics/openAccess |
| dc.subject | Endocarditis |
| dc.subject | Bacterièmia |
| dc.subject | Daptomicina |
| dc.subject | Fosfomicina |
| dc.subject | Estafilococ aureus resistent a la meticil·lina |
| dc.subject | Endocarditis |
| dc.subject | Bacteriemia |
| dc.subject | Daptomicina |
| dc.subject | Fosfomicina |
| dc.subject | Estafilococo aureus resistente a la meticilina |
| dc.subject | Endocarditis |
| dc.subject | Bacteremia |
| dc.subject | Daptomycin |
| dc.subject | Fosfomycin |
| dc.subject | Methicillin-resistant staphylococcus aureus |
| dc.subject | 61 |
| dc.title | Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial |
| dc.type | info:eu-repo/semantics/article |
| dc.type | info:eu-repo/semantics/publishedVersion |
Related documents
Other documents of the same author
Pujol, Miquel; Miró, José-María; Shaw, Evelyn; Aguado, Jose-María; San-Juan, Rafael; Puig-Asensio, Mireia; Pigrau, Carles; Calbo Sebastián, Esther; Montejo, Miguel; Rodriguez-Álvarez, Regino; Garcia-Pais, María-Jose; Pintado, Vicente; Escudero-Sánchez, Rosa; Lopez-Contreras, Joaquín
Vidal, Francesc; López-Dupla, Miguel; Laguno Centeno, Montserrat; Veloso, Sergi; Mallolas Masferrer, Josep; Murillas, Javier; Cifuentes, Carmen; Gallart, Lluis; Auguet, Teresa; Sampériz, Gloria; Payeras, Antoni; Hernandez, Pilar; Arnedo Valero, Mireia; Gatell, José M.; Richart, Cristóbal
Vilchez, Helem; Escudero-Sánchez, Rosa; Fernandez-Sampedro, Marta; Murillo Rubio, Oscar; Auñón, Álvaro; Rodriguez-Pardo, Dolors; Jover-Sáenz, Alfredo; del Toro López, María Dolores; Rico Nieto, Alicia; Falgueras, Luis; Praena-Segovia, Julia; Guío, Laura; Iribarren, José A.; Lora-Tamayo, Jaime; Benito, Natividad; Morata, Laura; Ramírez Rosales, Antonio; Riera, Melchor; Universitat Autònoma de Barcelona
López Medrano, Francisco; Fernández Ruiz, Mario; Silva, José Tiago; Carver, Peggy L.; Delden, Christian van; Merino, Esperanza; Pérez Saez, María José; Montero, Milagros; Coussement, Julien; Abreu Mazzolin, Milene de; Cervera, Carlos; Santos, Lidia; Sabé, Nuria; Scemla, Anne; Cordero, Elisa; Cruzado Vega, Leónidas; Martín Moreno, Paloma Leticia; Len, Óscar; Rudas, Eddison; Ponce de León, Alfredo; Arriola, Mariano; Lauzurica, Ricardo; David, Miruna D.; González Rico, Claudia; Henríquez Palop, Fernando; Fortún, Jesús; Nucci, Marcio; Manuel, Oriol; Paño Pardo, José Ramón; Montejo, Miguel; Vena, Antonio; Sánchez Sobrino, Beatriz; Mazuecos, Auxiliadora; Pascual, Julio (Pascual Santos); Horcajada, Juan Pablo; Lecompte, Thanh; Moreno Camacho, Ma. Asunción; Carratalà, Jordi; Blanes, Marino; Perelló Carrascosa, Manuel; Muñoz, Patricia; Andrés, Amado; Aguado, José María; Spanish Network for Research in Infectious Diseases (REIPI); Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC); Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Swiss Transplant Cohort Study (STCS)
López Medrano, Francisco; Fernández Ruiz, Mario; Silva, José Tiago; Carver, Peggy L.; Delden, Christian van; Merino, Esperanza; Pérez Saez, María José; Montero, Milagros; Coussement, Julien; Abreu Mazzolin, Milene de; Cervera, Carlos; Santos, Lidia; Sabé, Nuria; Scemla, Anne; Cordero, Elisa; Cruzado Vega, Leónidas; Martín Moreno, Paloma Leticia; Len, Óscar; Rudas, Eddison; Ponce de León, Alfredo; Arriola, Mariano; Lauzurica, Ricardo; David, Miruna D.; González Rico, Claudia; Henríquez Palop, Fernando; Fortún, Jesús; Nucci, Marcio; Manuel, Oriol; Paño Pardo, José Ramón; Montejo, Miguel; Vena, Antonio; Sánchez Sobrino, Beatriz; Mazuecos, Auxiliadora; Pascual, Julio (Pascual Santos); Horcajada, Juan Pablo; Lecompte, Thanh; Moreno Camacho, Ma. Asunción; Carratalà, Jordi; Blanes, Marino; Perelló Carrascosa, Manuel; Muñoz, Patricia; Andrés, Amado; Aguado, José María; Spanish Network for Research in Infectious Diseases (REIPI); Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC); Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Swiss Transplant Cohort Study (STCS)